Cuban Ready To Distribute Generic Drugs If CMS Agrees To March-In Alternative

By Maaisha Osman / April 11, 2024 at 2:45 PM
Updated Story Mark Cuban, founder of the Mark Cuban Cost Plus Drug Company, tells Inside Health Policy he could take on the role of distributing the drugs should CMS back drug-pricing advocates’ proposed march-in alternative to license entities to make generic versions of expensive drugs like Xtandi. The advocates tell IHP the proposal they shared with CMS this week could be used beyond Xtandi for other expensive drugs developed in part with taxpayers’ funding. Cuban...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.